Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (258) Arrow Down
Filter Results: (258) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (120,194)
    • Faculty Publications  (258)

    Show Results For

    • All HBS Web  (120,194)
      • Faculty Publications  (258)

      Hamermesh, Richard G.Remove Hamermesh, Richard G. →

      ← Page 7 of 258 Results →
      • January 2007 (Revised January 2007)
      • Background Note

      Note on the U.S. Food and Drug Administration

      By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
      Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details
      Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Medical Devices and Supplies Industry; Biotechnology Industry; Public Administration Industry; United States
      Citation
      Educators
      Purchase
      Related
      Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
      • January 2007
      • Background Note

      Note on Biotech Business Development

      By: Richard G. Hamermesh and Robert F. Higgins
      Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious... View Details
      Keywords: Agreements and Arrangements; Entrepreneurship; Intellectual Property; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., and Robert F. Higgins. "Note on Biotech Business Development." Harvard Business School Background Note 807-032, January 2007.
      • January 2007 (Revised June 2007)
      • Background Note

      Technology Transfer at U.S. Universities

      By: Richard G. Hamermesh, Josh Lerner and David Kiron
      Technology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the... View Details
      Keywords: Higher Education; Information Technology; Laws and Statutes; Education Industry; Technology Industry; United States
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., Josh Lerner, and David Kiron. "Technology Transfer at U.S. Universities." Harvard Business School Background Note 807-124, January 2007. (Revised June 2007.)
      • December 2006
      • Supplement

      Dental Corp--video

      By: Richard G. Hamermesh
      Keywords: Media; Health Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G. "Dental Corp--video." Harvard Business School Video Supplement 807-703, December 2006.
      • November 2006 (Revised May 2007)
      • Supplement

      Corporate Venture Capital at Eli Lilly

      By: Richard G. Hamermesh
      Keywords: Management; Business Ventures; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G. "Corporate Venture Capital at Eli Lilly." Harvard Business School Video Supplement 807-705, November 2006. (Revised May 2007.)
      • October 2006 (Revised August 2007)
      • Case

      Calloway Laboratory: Pee for Profit

      By: Richard G. Hamermesh and David Kiron
      Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
      Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
      • September 2006
      • Teaching Note

      Corporate Venture Capital at Eli Lilly (TN)

      By: Richard G. Hamermesh and Erin Seefeld
      Keywords: Venture Capital; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and Erin Seefeld. "Corporate Venture Capital at Eli Lilly (TN)." Harvard Business School Teaching Note 807-059, September 2006.
      • September 2006
      • Supplement

      Wu Xi Pharmatech

      By: Richard G. Hamermesh
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G. "Wu Xi Pharmatech." Harvard Business School Video Supplement 807-701, September 2006.
      • June 2006
      • Supplement

      Cutlass Capital, L.P.: Discussion with David Hetz and Jon Osgood

      By: Richard G. Hamermesh
      Keywords: Capital; Financial Services Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G. "Cutlass Capital, L.P.: Discussion with David Hetz and Jon Osgood." Harvard Business School Video Supplement 806-719, June 2006.
      • 2006
      • Book

      New Business Ventures and the Entrepreneur

      By: Michael J. Roberts, Howard H. Stevenson, William A. Sahlman, Paul Marshall and Richard G. Hamermesh
      Keywords: Entrepreneurship
      Citation
      Find at Harvard
      Related
      Roberts, Michael J., Howard H. Stevenson, William A. Sahlman, Paul Marshall and Richard G. Hamermesh, eds. New Business Ventures and the Entrepreneur. 6th ed. New York: McGraw-Hill/Irwin, 2006.
      • May 2006
      • Teaching Note

      WuXi PharmaTech (TN)

      By: Richard G. Hamermesh and Erin Seefeld
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and Erin Seefeld. "WuXi PharmaTech (TN)." Harvard Business School Teaching Note 806-180, May 2006.
      • March 2006
      • Teaching Note

      Cutlass Capital, L.P. (TN)

      By: Richard G. Hamermesh and Erin Seefeld
      Teaching Note to 805075. View Details
      Keywords: Financial Services Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and Erin Seefeld. "Cutlass Capital, L.P. (TN)." Harvard Business School Teaching Note 806-155, March 2006.
      • March 2006
      • Teaching Note

      Conor Medsystems (TN)

      By: Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld
      Teaching Note to (804-180). View Details
      Keywords: Health Industry
      Citation
      Purchase
      Related
      Higgins, Robert F., Richard G. Hamermesh, and Erin Seefeld. "Conor Medsystems (TN)." Harvard Business School Teaching Note 806-150, March 2006.
      • March 2006
      • Teaching Note

      Stan Lapidus: Profile of a Medical Entrepreneur (TN)

      By: Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld
      Teaching Note to (805-087). View Details
      Keywords: Personal Development and Career; Entrepreneurship; Business Startups; Biotechnology Industry; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Higgins, Robert F., Richard G. Hamermesh, and Erin Seefeld. "Stan Lapidus: Profile of a Medical Entrepreneur (TN)." Harvard Business School Teaching Note 806-149, March 2006.
      • March 2006
      • Teaching Note

      Fred Khosravi and AccessClosure (TN)

      By: Richard G. Hamermesh and Erin Seefeld
      Teaching Note to (806-044). View Details
      Keywords: Entrepreneurship; Decision Choices and Conditions; Mergers and Acquisitions; Business Exit or Shutdown; Initial Public Offering; Medical Devices and Supplies Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and Erin Seefeld. "Fred Khosravi and AccessClosure (TN)." Harvard Business School Teaching Note 806-141, March 2006.
      • March 2006 (Revised February 2009)
      • Teaching Note

      Molecular Insight Pharmaceuticals, Inc. (TN)

      By: Richard G. Hamermesh and Erin Seefeld
      Teaching Note to (805-067). View Details
      Keywords: Pharmaceutical Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and Erin Seefeld. "Molecular Insight Pharmaceuticals, Inc. (TN)." Harvard Business School Teaching Note 806-140, March 2006. (Revised February 2009.)
      • February 2006 (Revised July 2007)
      • Case

      Corporate Venture Capital at Eli Lilly

      By: Richard G. Hamermesh, Ron Laufer and David Lane
      Reviews the role of corporate venture capital and its history at Eli Lilly. Also presents a challenging venture investment opportunity. View Details
      Keywords: Venture Capital; Investment; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., Ron Laufer, and David Lane. "Corporate Venture Capital at Eli Lilly." Harvard Business School Case 806-092, February 2006. (Revised July 2007.)
      • February 2006
      • Teaching Note

      John Moran and the Orthopedics Industry (TN)

      By: Richard G. Hamermesh
      Teaching Note to 805026. View Details
      Keywords: Health Industry
      Citation
      Related
      Hamermesh, Richard G. "John Moran and the Orthopedics Industry (TN)." Harvard Business School Teaching Note 806-125, February 2006.
      • January 2006 (Revised May 2007)
      • Case

      Endo Pharmaceuticals (A): From LBO to...?

      By: Richard G. Hamermesh and Brian DeLacey
      Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company. View Details
      Keywords: Private Equity; Initial Public Offering; Leveraged Buyouts; Mergers and Acquisitions; Health Care and Treatment; Pharmaceutical Industry; United States
      Citation
      Educators
      Purchase
      Related
      Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (A): From LBO to...?" Harvard Business School Case 806-064, January 2006. (Revised May 2007.)
      • January 2006 (Revised May 2007)
      • Supplement

      Endo Pharmaceuticals (B): Merger Decision

      By: Richard G. Hamermesh and Brian DeLacey
      Keywords: Mergers and Acquisitions; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (B): Merger Decision." Harvard Business School Supplement 806-065, January 2006. (Revised May 2007.)
      • ←
      • 7
      • 8
      • …
      • 12
      • 13
      • →
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.